Related Experiment Video
Updated: May 18, 2026

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
Published on: May 19, 2020
National, state, and local area vaccination coverage among children aged 19-35 months--United States, 2011
Insights
Childhood vaccination coverage in the U.S. remains high for many diseases, but disparities exist. Maintaining high immunization rates is crucial to prevent disease resurgence, especially in vulnerable populations.
Area of Science:
- Pediatric Public Health
- Immunization Science
- Epidemiology
Background:
- High childhood vaccination coverage has led to historically low disease rates in the U.S.
- Maintaining current vaccination levels is essential to prevent disease resurgence, particularly in underserved populations.
Purpose of the Study:
- To report national, state, and local vaccination coverage data for children aged 19-35 months using the 2011 National Immunization Survey (NIS).
- To assess vaccination coverage trends for routine childhood vaccines and identify disparities.
Main Methods:
- Analysis of data from the 2011 National Immunization Survey (NIS).
- Assessment of vaccination coverage rates for children born between January 2008 and May 2010.
- Comparison of coverage rates against Healthy People 2020 targets and identification of socioeconomic disparities.
Main Results:
- Coverage for measles, mumps, rubella (MMR), poliovirus, and varicella vaccines exceeded the 90% Healthy People 2020 target.
- Increased coverage was observed for birth dose hepatitis B (HepB), hepatitis A (HepA), rotavirus, and Haemophilus influenzae type b (Hib) vaccines.
- Children below the poverty level exhibited lower vaccination coverage for several key vaccines, including diphtheria, tetanus toxoid, and acellular pertussis (DTaP) and pneumococcal conjugate vaccine (PCV).
Conclusions:
- While overall childhood vaccination coverage remains strong, persistent disparities, particularly among low-income populations, require targeted interventions.
- Continued public-private partnerships are vital to sustain high immunization rates and improve coverage for newer vaccines nationwide.
Abstract:
High vaccination coverage in children by age 2 years has resulted in historically low levels of most vaccine-preventable diseases in the United States, but coverage must be maintained to reduce the burden of disease further and prevent a resurgence of these diseases, particularly in populations with lower vaccination coverage. This report describes national, state, and selected local area vaccination coverage by age 19-35 months for children born during January 2008-May 2010, based on 2011 National Immunization Survey (NIS) results. Vaccination coverage remained above the national Healthy People 2020 target* of 90% for ≥1 dose measles, mumps, rubella vaccine (MMR) (91.6%), ≥3 doses of hepatitis B vaccine (HepB) (91.1%), ≥3 doses of poliovirus vaccine (93.9%), and ≥1 dose of varicella vaccine (90.8%). For the birth dose of HepB, coverage increased from 64.1% in 2010 to 68.6% in 2011; for the more recently recommended ≥2 doses of hepatitis A vaccine (HepA) and rotavirus vaccines, coverage increased from 49.7% to 52.2% and from 59.2% to 67.3%, respectively; and for the full series of Haemophilus influenzae type b vaccine (Hib), coverage increased from 66.8% to 80.4%, reflecting recovery from the Hib shortage that occurred during December 2007-September 2009. The percentage of children who had not received any vaccinations remained at <1%. Children living below the poverty level had lower coverage than children living at or above poverty for ≥4 doses of diphtheria, tetanus toxoid, and acellular pertussis vaccine (DTaP) and ≥4 doses of pneumococcal conjugate vaccine (PCV) (by 6 percentage points each); the full Hib series (by 8 percentage points); and for rotavirus vaccination (by 10 percentage points). Continued partnerships among national, state, local, private, and public entities are needed to sustain current coverage levels and ensure that coverage for the more recently recommended vaccines continues to increase for all children.
More Related Videos
05:31Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
12:09Measuring Influenza Neutralizing Antibody Responses to A(H3N2) Viruses in Human Sera by Microneutralization Assays Using MDCK-SIAT1 Cells
Published on: November 22, 2017
Related Concept Videos
Vaccinations
Vaccines
Drug Dosing: Infants and Children
Healthcare Agencies II
Parish nursing is a growing specialty nursing profession that focuses on holistic healthcare, health promotion, and illness prevention. It blends professional nursing practice with a health ministry, focusing on health and healing within the context of a Christian community. Parish nurses serve as health educators, referral sources, and lay...
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Investigation of Disease Outbreaks